Get started
Author

S. Mandal

Observed names: S Mandal, Samar Mandal
Institution: Bose Institute
ORCID: 0009-0002-6249-0546
Observed ORCID: 0009-0002-6249-0546
OpenAlex ID: A5012020504
HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis
2022 · Santam Chakraborty, Sanjoy Chatterjee, et al. · Radiotherapy and Oncology · 45
Resource requirements and reduction in cardiac mortality from deep inspiration breath hold (DIBH) radiation therapy for left sided breast cancer patients: A prospective service development analysis
2018 · Sanjoy Chatterjee, Santam Chakraborty, et al. · Practical Radiation Oncology · 31
Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial
2020 · Sanjoy Chatterjee, Santam Chakraborty, et al. · Trials · 27
PDF
Alleviating Morbidity From Locally Advanced Breast Cancer Using a Practical and Short Radiation Therapy Regimen: Results of the HYPORT Palliative Studies
2023 · Sanjoy Chatterjee, Santam Chakrabarty, et al. · International Journal of Radiation Oncology*Biology*Physics · 23
Prioritizing Delivery of Cancer Treatment During a COVID-19 Lockdown: The Experience of a Clinical Oncology Service in India
2021 · Indranil Mallick, Santam Chakraborty, et al. · JCO Global Oncology · 11
Simultaneous Integrated Boost: Improving the Patient Journey During Breast Cancer Radiotherapy Safely
2018 · S. Chatterjee, A. Mahata, et al. · Clinical Oncology · 11
Actual gains in dosimetry and treatment delivery efficiency from volumetric modulated arc radiotherapy for inoperable, locally advanced lung cancer over five-field forward-planned intensity-modulated radiotherapy
2017 · RK Shrimali, M Arunsingh, et al. · Indian Journal of Cancer · 5
Can Deep Inspiration Breath Hold Radiation Therapy (DIBH) for Breast Cancers be Cost Effective in Developing Nations?
2018 · S. Chakarborty, S. Chatterjee, et al. · International Journal of Radiation Oncology*Biology*Physics · 4
PDF
PO-0985: Hypofractionated radiotherapy with SIB in advanced incurable breast cancer-HYPORT B study
2020 · R. Santosham, S. Chatterjee, et al. · Radiotherapy and Oncology · 3
18 F ‐fluorodeoxyglucose PET‐CT ‐guided pelvic chemoradiation therapy using helical tomotherapy for locally advanced carcinoma cervix without para‐aortic nodal disease: Clinical and patient‐reported outcomes from a prospective phase 2 study
2024 · Rimpa Basu Achari, Santam Chakraborty, et al. · Journal of Medical Imaging and Radiation Oncology · 1
Quality Assurance in Radiotherapy (RT)-Specific Trials: Indian Scenario
2024 · A. Mahata, S. Chakraborty, et al. · Clinical Oncology · 1
PDF
701: Cardiac safety of ultra-Hypofractionated RT in the HYPORT Adjuvant randomized trial (NCT03788213)
2024 · Sanjoy Chatterjee, Santam Chakraborty, et al. · Radiotherapy and Oncology · 1
EP-1763: Acute toxicity and in-vivo dosimetry of a two week hypofractionated schedule within the HYPORT study
2017 · A. Saha, G. Goswami, et al. · Radiotherapy and Oncology · 1
Characteristic study of Straw tube detector for future heavy ion experiment
2026 · S. Mandal, S. Das, et al. · Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment
Clinical and Demographic Characteristics, along with Oncological Outcomes, Following Multimodal Treatment of Sinonasal Carcinoma
2025 · A. Ravi, A.V. R, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Prophylactic Para Aortic Irradiation vs Pelvic Radiotherapy in Pelvic node-positive Carcinoma Cervix in the setting of concurrent chemoradiation: A phase II Open-label Multi centric Randomized Controlled Trial (PRO-PARA)
2024 · Tapesh Bhattacharyya, Santam Chakraborty, et al. · medRxiv
PDF
Hypo-Fractionated Palliative QUADSHOT Radiotherapy and Concurrent CDDP in Patients with LAHNSCC: Toxicities and Clinical Outcomes
2023 · S. Bhasker, J. Pattanaik, et al. · International Journal of Radiation Oncology*Biology*Physics
Patient-Reported Outcomes Evaluating the Impact of Hypo-Fractionated Palliative Quadshot Radiotherapy and Concurrent CDDP Treatment on Health-Related Quality of Life in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
2023 · J. Pattanaik, S. Bhasker, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
PO-1425 PETCT guided chemoradiation in carcinoma cervix: Prospective clinical and patient reported outcomes
2023 · R. Basu Achari, S. Chakraborty, et al. · Radiotherapy and Oncology
Impact of COVID-19 on quality of care indicators in patients of carcinoma cervix treated with definitive radiotherapy: A cross-sectional study
2022 · Santam Chakraborty, Tapesh Bhattacharyya, et al.
Integrating The Boost: Development Of A Hybrid Volumetric Modulated Arc Based Simultaneous Integrated Boost Class Solution For Breast Cancer
2021 · Sanjoy Chatterjee, Anurupa Mahata, et al. · Research Square
PDF
How Much Extra Resource do we Spend to Protect the Heart from Radiation Damage and for What Gain?
2017 · M. Arunsingh, A. Mahata, et al. · Clinical Oncology
Works count: 22
Citation count: 163
H-index: 6
I10-index: 6
Year
Topic
Type